Bayesian Capital Management, LP Inogen Inc Transaction History
Bayesian Capital Management, LP
- $582 Million
- Q1 2025
A detailed history of Bayesian Capital Management, LP transactions in Inogen Inc stock. As of the latest transaction made, Bayesian Capital Management, LP holds 14,099 shares of INGN stock, worth $89,669. This represents 0.02% of its overall portfolio holdings.
Number of Shares
14,099Holding current value
$89,669% of portfolio
0.02%Shares
6 transactions
Others Institutions Holding INGN
# of Institutions
140Shares Held
19.6MCall Options Held
19.3KPut Options Held
11.3K-
Black Rock Inc. New York, NY1.63MShares$10.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.54MShares$9.8 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.03MShares$6.54 Million0.02% of portfolio
-
Kent Lake Pr LLC Anasco, PR1MShares$6.38 Million3.3% of portfolio
-
Camber Capital Management LP Boston, MA975KShares$6.2 Million0.26% of portfolio
About Inogen Inc
- Ticker INGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 22,866,500
- Market Cap $145M
- Description
- Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...